Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGN
2901
Legence Corp
LGN
$4.07B
| $812K | ﹤0.01% |
9,533
-710
| -7% | -$57.8K |
|
2902
AC Immune
ACIU
$265M
| $812K | ﹤0.01% |
340,082
-50,083
| -13% | -$138K |
|
2903
Destination XL Group
DXLG
$34.5M
| $811K | ﹤0.01% |
1,210,584
-337,273
| -22% | -$222K |
|
2904
Natural Alternatives International
NAII
$12.3M
| $803K | ﹤0.01% |
335,789
-18,950
| -5% | -$49.5K |
|
2905
BGSF Inc
BGSF
$54.7M
| $793K | ﹤0.01% |
138,783
-7,424
| -5% | -$41.3K |
|
2906
Acumen Pharmaceuticals
ABOS
$206M
| $779K | ﹤0.01% |
291,559
+171,803
| +143% | +$424K |
|
2907
Alpha Pro Tech
APT
$53.9M
| $771K | ﹤0.01% |
137,103
-232
| -0.2% | -$1.21K |
|
2908
Airgain
AIRG
$68.4M
| $762K | ﹤0.01% |
120,975
+30,264
| +33% | +$201K |
|
|
VZLA
2909
Vizsla Silver
VZLA
$1.32B
| $754K | ﹤0.01% |
228,550
+147,966
| +184% | +$514K |
|
|
BULL
2910
Webull Corp
BULL
$4.68B
| $752K | ﹤0.01% |
+115,345
| New | +$747K |
|
2911
Workiva
WK
$4.08B
| $743K | ﹤0.01% |
15,320
-1,790
| -10% | -$92.2K |
|
|
SOHU
2912
Sohu.com
SOHU
$355M
| $739K | ﹤0.01% |
60,950
-16,711
| -22% | -$240K |
|
2913
AlTi Global
ALTI
$364M
| $732K | ﹤0.01% |
202,742
+105,061
| +108% | +$363K |
|
2914
Gaia
GAIA
$32.3M
| $728K | ﹤0.01% |
346,627
-75,990
| -18% | -$196K |
|
2915
United Bancorp
UBCP
$88.9M
| $723K | ﹤0.01% |
45,509
+353
| +0.8% | +$5.57K |
|
2916
Vince Holding Corp
VNCE
$109M
| $719K | ﹤0.01% |
100,504
+52,105
| +108% | +$240K |
|
2917
Codexis
CDXS
$157M
| $709K | ﹤0.01% |
313,386
+28,750
| +10% | +$71.6K |
|
2918
Avalo Therapeutics
AVTX
$849M
| $707K | ﹤0.01% |
38,158
-2,663
| -7% | -$42.1K |
|
2919
Montauk Renewables
MNTK
$325M
| $700K | ﹤0.01% |
448,818
-287,766
| -39% | -$426K |
|
2920
Kyverna Therapeutics
KYTX
$427M
| $699K | ﹤0.01% |
78,419
| – | – |
|
2921
CPS Technologies
CPSH
$75M
| $697K | ﹤0.01% |
126,290
+33,615
| +36% | +$197K |
|
|
ABX
2922
Abacus Global Management
ABX
$908M
| $694K | ﹤0.01% |
+64,845
| New | +$592K |
|
|
LGCY
2923
Legacy Education Inc
LGCY
$131M
| $694K | ﹤0.01% |
58,950
+34,203
| +138% | +$403K |
|
2924
LGL Group
LGL
$84.6M
| $686K | ﹤0.01% |
99,240
| – | – |
|
2925
Strawberry Fields REIT
STRW
$197M
| $684K | ﹤0.01% |
49,737
+11,598
| +30% | +$151K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.